Vimarsana.com

Latest Breaking News On - Kidney week - Page 1 : vimarsana.com

Sparsentan Bests Irbesartan for Rare, Progressive Kidney Disease

Sparsentan Bests Irbesartan for Rare, Progressive Kidney Disease
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

Minnesota
United-states
New-york
Sparsentan-filspari
Michellen-rheault
University-of-minnesota-medical-school-in-minneapolis
National-kidney-foundation
Minnesota-medical-school
Spring-clinical
Kidney-week
Travere-therapeutics
New-york-city

Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China

Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Stockholm
Sweden
Macau
Singapore
Hong-kong
China
United-states
South-korea
Taiwan
American
Chinese
Renee-aguiar-lucander

Calliditas Therapeutics: Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China

Calliditas Therapeutics: Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Singapore
Macau
Stockholm
Sweden
Taiwan
South-korea
United-states
China
Hong-kong
American
Chinese
Renee-aguiar-lucander

Calliditas Therapeutics' (CALT) Partner Everest Medicines Starts Commercial Launch of Nefecon in China

Calliditas Therapeutics' (CALT) Partner Everest Medicines Starts Commercial Launch of Nefecon in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
China
American
Chinese
Renee-aguiar-lucander
American-society-of-nephrology
Calliditas-therapeutics
Everest-medicines
American-society
Kidney-week

Avacopan Achieves High Remission Rates in ANCA-Associated Vasculitis

Avacopan Achieves High Remission Rates in ANCA-Associated Vasculitis
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

Maryland
United-states
Pennsylvania
Philadelphia
Faten-aqeel
Johns-hopkins-university-in-baltimore
Kidney-week
Johns-hopkins-university
Birmingham-vasculitis-activity-score

Why Is Alpine Immune Sciences Stock Trading Higher Today? - Alpine Immune Sciences (NASDAQ:ALPN)

Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities.

United-states
American
Bloomberg
American-society-of-nephrology
Chinook-therapeutics-inc
Alpine-immune-sciences-inc
Alpine-immune
American-society
Kidney-week
Chinook-therapeutics

Breast, Lung, Brain, Bone Cancer | News, Research & Treatment Articles

More news  » Challenges Faced By Oncology Nurses https://polldaddy.com/poll/10020480/ Editorial Board Eucharia Borden, MSW, LCSW, OSW-C Ann J.

Massachusetts
United-states
Canada
California
Florida
Netherlands
Dana-farber-cancer-institute
Oregon
Tempe
Arizona
University-of-mississippi-medical-center
Mississippi

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights

– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April –– Phase 1 tr...

Massachusetts
United-states
Boston
American
Douglasa-treco
Stefan-riley
Christine-obrien
Inozyme-pharma
Matt-pera
Sagar-nigwekar
European-calcified-tissue-society-congress
Corporate-communications

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript

Apellis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.73 EPS, expectations were $-0.66. Apellis Pharmaceuticals, Inc.

United-states
American
America
Raymond-james
Tim-sullivan
Tazeen-ahmad
Colleen-kusy
Salveen-richter
Cedric-francois
Jon-miller
Yigal-nochomovitz
Madam-townsend

Baxter To Spin-Off Vantive (Kidney Care Unit) In July 2024

On February 8, 2024, Baxter International Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a...

United-states
China
Australia
Chicago
Illinois
Baxter-centrella
Matt-harbaugh
Chris-toth
Hillrom-progressa
Baxter-sharesource
Iv-solutions
Davita-inc

vimarsana © 2020. All Rights Reserved.